The role of transcription factor PU.I in the activity of the intronic enhancer of the eosinophil-derived neurotoxin (RNS2) gene

Blood

Volumn 91, Issue 6, 1998, Pages 2126-2132

  Van Dijk, Thamar B ^a   Caldenhoven, Eric ^a   Raaijmakers, Jan A M ^a   Lammers, Jan Willem J ^a   Koenderman, Leo ^a   De Groot, Rolf P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL PROTEIN X; GENE PRODUCT; NEUROTOXIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PU.I; UNCLASSIFIED DRUG;

ALLERGY; ARTICLE; CELL LINE; CELL STRAIN HL 60; CONTROLLED STUDY; EOSINOPHIL; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; INTRON; PARASITISM; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0032520934     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.2126     Document Type: Article

References (49)

1. Kroegel C, Warner JA, Virchow JC Jr, Matthys H: Pulmonary immune cells in health and disease: the eosinophil leucocyte (part II). Eur Respir J 7:743, 1994
2. Gleich GJ, Adolphson CR: The eosinophilic leukocyte: Structure and function. Adv Immunol 39:177, 1986
3. Gundel RH, Letts LG, Gleich GJ: Human eosinophil major basic protein induces airway constriction and airwayhyperresponsiveness in primates. J Clin Invest 87:1470, 1991
4. Yazdanbakhsh M, Tai PC, Spry CJ, Gleich GJ, Roos D: Synergism between eosinophil cationic protein and oxygen metabolites in killing of schistosomula of Schistosoma mansoni. J Immunol 138:3443, 1987
5. Kroegel C, Virchow JC Jr, Luttmann W, Walker C, Warner JA: Pulmonary immune cells in health and disease: The eosinophil leucocyte (part I). Eur Respir J 7:519, 1994
6. Hamann KJ, Barker RL, Ten RM, Gleich GJ: The molecular biology of eosinophil granule proteins. Int Arch Appl Immunol 94:202, 1991
7. Hamann KJ, Barker RL, Loegering DA, Pease LR, Gleich GJ: Sequence of human eosinophil-derived neurotoxin cDNA: Identity of deducedamino acid sequence with human nonsecretory ribonucleases. Gene 83:161, 1989
8. Barker RL, Loegering DA, Ten RM, Hamann KJ, Pease LR, Gleich GJ: Eosinophil cationic protein cDNA. Comparison with other toxic cationicproteins and ribonucleases. J Immunol 143:952, 1989
9. Rosenberg HF, Tenen DG, Ackerman SJ: Molecular cloning of the human eosinophil-derived neurotoxin: A member of the ribonuclease gene family. Proc Natl Acad Sci USA 86:4460, 1989
10. Rosenberg HF, Ackerman SJ, Tenen DG: Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J Exp Med 170:163, 1989
11. Hamann KJ, Ten RM, Loegering DA, Jenkins RB, Heise MT, Schad CR, Pease LR, Gleich-GJ, Barker RL: Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: Evidence for intronless coding sequences in the ribonuclease gene superfamily. Genomics 7:535, 1990
12. Gruart V, Truong MJ, Plumas J, Zandecki M, Kusnierz JP, Prin L, Vinatier D, Capron A, Capron M: Decreased expression of eosinophil peroxidase and major basic protein messenger RNAs during eosinophil maturation. Blood 79:2592, 1992
13. Tiffany HL, Handen JS, Rosenberg HF: Enhanced expression of the eosinophil-derived neurotoxin ribonuclease (RNS2) gene requires interaction between the promoter and intron. J Biol Chem 271:12387, 1996
14. Handen JS, Rosenberg HF: Intronic enhancer activity of the eosinophil-derived neurotoxin (RNS2) and eosinophil cationic protein (RNS3) genes is mediated by an NFAT-1 consensus binding sequence. J Biol Chem 272:1665, 1997
15. Janknecht R, Nordheim A: Gene regulation by Ets proteins. Biochim Biophys Acta 1155:346, 1993
16. Karim FD, Urness LD, Thummel CS, Klemsz MJ, McKercher SR, Celada A, Van-Beveren-C, Maki RA, Gunther CV, Nye JA, et al: The ETS-domain: A new DNA-binding motif that recognizes a purine-rich core. Genes Dev 4:1451, 1990
17. Kodandapani R, Pio F, Ni CZ, Piccialli G, Klemsz M, McKercher S, Maki RA, Ely KR: A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex. Nature 380:456, 1996
18. Klemsz MJ, McKercher SR, Celada A, van Beveren C, Maki RA: The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113, 1990
19. Galson DL, Hensold JO, Bishop TR, Schalling M, D'Andrea AD, Jones C, Auron PE, Housman DE: Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis. Mol Cell Biol 13:2929, 1993
20. Hromas R, Orazi A, Neiman RS, Maki R, Van Beveran C, Moore J, Klemsz M: Hematopoietic lineage-and stage-restricted expression of the ETS oncogene family member PU.1. Blood 82:2998, 1993
21. Chen HM, Zhang P, Voso MT, Hohaus S, Gonzalez DA, Glass CK, Zhang DE, Tenen DG: Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood 85:2918, 1995
22. Moulton KS, Semple K, Wu H, Glass CK: Cell-specific expression of the macrophage scavenger receptor gene is dependent on PU.1 and a composite AP-1/ets motif. Mol Cell Biol 14:4408, 1994
23. Pahl HL, Scheibe RJ, Zhang DE, Chen HM, Galson DL, Maki RA, Tenen DG: The proto-oncogene PU.1 regulates expression of the myeloid-specific CD11b promoter. J Biol Chem 268:5014, 1993
24. Rosmarin AG, Caprio D, Levy R, Simkevich C: CD18 (beta 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity. Proc Natl Acad Sci USA 92:801, 1995
25. Perez C, Coeffier E, Moreau Gachelin F, Wietzerbin J, Benech PD: Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fc gamma receptor. Mol Cell Biol 14:5023, 1994
26. Ford AM, Bennett CA, Healy LE, Towatari M, Greaves MF, Enver T: Regulation of the myeloperoxidase enhancer binding proteins Pu1, C-EBP alpha, -beta, and -delta during granulocyte-lineage specification. Proc Natl Acad Sci USA 93:10838, 1996
27. Oelgeschlager M, Nuchprayoon I, Luscher B, Friedman AD: C/EBP, c-Myb, and PU.1 cooperate to regulate the neutrophil elastase promoter. Mol Cell Biol 16:4717, 1996
28. Feinman R, Qiu WQ, Pearse RN, Nikolajczyk BS, Sen R, Sheffery M, Ravetch JV: PU.1 and an HLH family member contribute to the myeloid-specific transcription of the Fc gamma RIIIA promoter. EMBO J 13:3852, 1994
29. Sturrock A, Franklin KF, Hoidal JR: Human proteinase-3 expression is regulated by PU.1 in conjunction with a cytidine-rich element. J Biol Chem 271:32392, 1996
30. Smith LT, Hohaus S, Gonzalez DA, Dziennis SE, Tenen DG: PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. Blood 88:1234, 1996
31. Zhang DE, Hetherington CJ, Chen HM, Tenen DG: The macrophage transcription factor PU.1 directs tissue-specific expression of the macrophage colony-stimulating factor receptor. Mol Cell Biol 14:373, 1994
32. Hohaus S, Petrovick MS, Voso MT, Sun Z, Zhang DE, Tenen DG: PU.1 (Spi-1) and C/EBP alpha regulate expression of the granulocyte-macrophage colony-stimulating factor receptor alpha gene. Mol Cell Biol 15:5830, 1995
33. Brass AL, Kehrli E, Eisenbeis CF, Storb U, Singh H: Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev 10:2335, 1996
34. Eisenbeis CF, Singh H, Storb U: Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev 9:1377, 1995
35. Scott EW, Simon MC, Anastasi J, Singh H: Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573, 1994
36. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE, Paige CJ, Maki RA: Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J 15:5647, 1996
37. Olson MC, Scott EW, Hack AA, Su GH, Tenen DG, Singh H, Simon MC: PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity 3:703, 1995
38. Voso MT, Bum TC, Wulf G, Lim B, Leone G, Tenen DG: Inhibition of hematopoiesis by competitive binding of transcription factor PU.1. Proc Natl Acad Sci USA 91:7932, 1994
39. de Groot RP, Karperien M, Pals C, Kruijer W: Characterization of the mouse junD promoter - High basal level activity due to an octamer motif. EMBO J 10:2523, 1991
40. de Groot RP, Pals C, Kruijer W: Transcriptional control of c-jun by retinoic acid. Nucleic Acids Res 19:1585, 1991
41. Chomczynski P, Sacchi N: Single step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 462:156, 1987
42. Caldenhoven E, Vandijk TB, Solari R, Armstrong J, Raaijmakers JAM, Lammers JWJ, Koenderman L, Degroot RP: STAT3 beta, a splice variant of transcription factor STAT3, is a dominant negative regulator of transcription. J Biol Chem 271:13221, 1996
43. de Groot RP, van Dijk TB, Caldenhoven E, Coffer PJ, Raaijmakers JAM, Lammers JJ, Koenderman L: Activation of 12-o-tetradecanoylphorbol-13-acetate response element-and dyad symmetry element-dependent transcription by interleukin-5 is mediated by Jun N-terminal kinase/stress-activated protein kinase kinases. J Biol Chem 272:2319, 1997
44. van Dijk TB, Bracke M, Caldenhoven E, Raaijmakers JA, Lammers JW, Koenderman L, de Groot RP: Cloning and characterization of Fc alpha Rb, a novel Fc alpha receptor (CD89) isoform expressed in eosinophils and neutrophils. Blood 88:4229, 1996
45. Futami J, Tsushima Y, Murato Y, Tada H, Sasaki J, Seno M, Yamada H: Tissue-specific expression of five human pancreatic-type RNases and RNase inhibitor in humans. DNA Cell Biol 16:413, 1997
46. Fischkoff SA: Graded increase in probability of eosinophilic differentiation of HL-60 promyelocytic leukemia cells induced by culture under alkaline conditions. Leuk Res 12:679, 1988
47. Carey JO, Posekany KJ, deVente JE, Pettit GR, Ways DK: Phorbol ester-stimulated phosphorylation of PU.1: Association with leukemic cell growth inhibition. Blood 87:4316, 1996
48. Lodie TA, Savedra R, Golenbock DT, van Beveren C, Maki RA, Fenton MJ: Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.I via activation of casein kinase II. J Immunol 158:1848, 1997
49. Gomolin HI, Yamaguchi Y, Paulpillai AV, Dvorak LA, Ackerman SJ, Tenen DG: Human eosinophil Charcot-Leyden crystal protein: Cloning and characterization of a lysophospholipase gene promoter. Blood 82:1868, 1993.